Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GeneraliFRA:ASG -0.78%55 3-Year EPS without NRI Growth Rate is 20.60% as of Jun. 2026, which is 265% above its 10-year median of 5.65. GuruFocus rates FRA:ASG with a GF Score™ of 55/100 and a GF Value™ of €41.29 (Fairly Valued). The stock has 2 warning signs investors should review. Among 400 Insurance companies, Generali ranks better than 56.5% on this metric.
During the past 12 months, Generali's average EPS without NRI Growth Rate was 60.30% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 20.60% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 13.80% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 6.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Generali was 55.00% per year. The lowest was -39.90% per year. And the median was 5.65% per year.
Generali (FRA:ASG) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Generali 3-Year EPS without NRI Growth Rate Related Terms
FRA:ASG vs BRK.A, AIG, HIG: 3-Year EPS without NRI Growth Rate Comparison
For the Insurance - Diversified subindustry, Generali's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Generali 3-Year EPS without NRI Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Generali's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Generali's 3-Year EPS without NRI Growth Rate falls into.
Generali 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 20.60% mean?
Generali (FRA:ASG) has a 3-Year EPS without NRI Growth Rate of 20.60% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Generali and its competitors. This is 265% above median its historical median of 5.65. According to the industry distribution chart, Generali ranks #174 out of 400 companies in the Insurance industry, placing it in the top 43.5%.
Is Generali's 3-Year EPS without NRI Growth Rate too high?
Generali's current 3-Year EPS without NRI Growth Rate of 20.60% is 265% above median its 10-year median of 5.65. The Insurance industry median 3-Year EPS without NRI Growth Rate is 16.35. Generali's value of 20.60% is 26% above this industry median. Based on the distribution chart, Generali ranks #174 out of 400 companies in the Insurance industry, which is above the industry midpoint. Overall, Generali has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Generali's 3-Year EPS without NRI Growth Rate compare to BRK.A and AIG?
According to the Insurance industry distribution chart, Generali ranks #174 out of 400 companies for 3-Year EPS without NRI Growth Rate. This puts Generali in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 16.35. Generali's value of 20.60% is 26% above this benchmark. While the company's 10-year median is 5.65 vs. the industry median of 16.35, Generali has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for an Insurance company?
The median 3-Year EPS without NRI Growth Rate among Insurance companies is 16.35, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Generali's current 3-Year EPS without NRI Growth Rate of 20.60% is 26% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Generali and its competitors. For the Insurance industry, the median 3-Year EPS without NRI Growth Rate is 16.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Generali's current 3-Year EPS without NRI Growth Rate is 20.60%, which is 265% above median its own 10-year median of 5.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generali stock overvalued right now?
Based on GuruFocus' analysis, Generali (FRA:ASG) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €44.35 — trading 7.4% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 20.60%, which is 265% above median its 10-year median of 5.65 and 26% above the Insurance industry median of 16.35. Generali's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Generali (FRA:ASG), the current 3-Year EPS without NRI Growth Rate is 20.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Generali (FRA:ASG) Overvalued in 2026?
Based on GuruFocus' analysis, Generali stock appears to be overvalued.
The current stock price of €44.35 is trading 7.4% above its estimated GF Value™ of €41.29.
GuruFocus considers Generali to be Fairly Valued.
Key valuation signals for FRA:ASG:
3-Year EPS without NRI Growth Rate: 20.60% (265% above median its 10-year median of 5.65)
GF Value™: €41.29 vs. price of €44.35 (7.4% above fair value)
Industry Position: 26% above the Insurance median (#174 of 400)
No single metric tells the full story. See the FRA:ASG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The roots of Generali date back to the 1830s and the Bora wind and rough seas that hit the Trieste region. Over that decade, Generali sought to expand throughout Italy, but growth was held back by the fragmented nature of Italy. The Italian Revolution in the 1840s paved the way for easier expansion in the country. After World War I, Trieste was handed back to Italy. The dissolution of the Austro-Hungarian Empire created a fragmented Europe and a fragmented Generali. To this day, Generali remains quite a diversified company, with its core operations remaining in the historical Austro-Hungarian countries of Austria, Central and Eastern Europe, Germany, and Italy. France is also an important contributor to life and savings.
55GF Score
Get the complete analysis for FRA:ASG
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ASG has been successfully added to your 
